The global Valsartan market volume was roughly 46 thousand tonnes in 2023 and is anticipated to grow at a CAGR of 4.65% during the forecast period until 2034.
Valsartan is prescribed for the management of hypertension and heart failure, as well as for enhancing post-heart attack survival rates. In heart failure patients, it may additionally reduce the likelihood of hospitalization due to the condition. Classified as an angiotensin receptor blocker (ARB), Valsartan functions by dilating blood vessels, thereby facilitating smoother blood flow. This action aids in lowering elevated blood pressure levels, consequently reducing the risk of strokes, myocardial infarctions, and renal complications.
The global Valsartan market is driven by several key factors. Firstly, the rising prevalence of hypertension and heart failure worldwide contributes significantly to the demand for Valsartan, as it is a widely prescribed medication for these conditions. Additionally, the increasing awareness among healthcare professionals and patients regarding the benefits of Valsartan in preventing cardiovascular events, such as strokes and heart attacks, fuels its adoption. Furthermore, the aging population globally, coupled with sedentary lifestyles and unhealthy dietary habits, has led to a surge in cardiovascular diseases, further driving the demand for Valsartan. Moreover, advancements in healthcare infrastructure and access to medical services in emerging economies have expanded the market reach of Valsartan. Additionally, the availability of generic versions of Valsartan has improved affordability and accessibility, stimulating market growth. Lastly, ongoing research and development efforts aimed at expanding the therapeutic applications of Valsartan, as well as the development of new formulations and combination therapies, contribute to its market expansion. The global Valsartan market is likely to reach approximately 75 thousand tonnes in 2034.
Geographically, North America is one of the prominent consumers of Valsartan and is likely to maintain its position in the upcoming years as well. The region's high prevalence of hypertension and cardiovascular diseases, coupled with advanced healthcare infrastructure and widespread access to medical services, underpins the extensive utilization of Valsartan. Additionally, North America's robust pharmaceutical industry and stringent regulatory standards ensure the availability of high-quality Valsartan formulations, further driving its consumption. Furthermore, increasing awareness among healthcare professionals and patients regarding the efficacy and benefits of Valsartan in preventing cardiovascular events reinforces its prominence in the region.
Based on end-use applications, the global Valsartan market is divided into Hypertension, Heart Failure, Heart Attack, and Others. Among these applications, Hypertension is the major application. Valsartan serves as a pivotal therapeutic option not only for hypertension but also for heart failure and post-myocardial infarction left ventricular failure, a condition characterized by the stiffening and enlargement of the heart's left pumping chamber. This medical breakthrough underscores Valsartan's efficacy as an angiotensin II receptor blocker (ARB), exerting its mechanism of action by inhibiting the vasoconstrictive effects of a key substance in the body. By promoting vasodilation, Valsartan effectively reduces blood pressure, enhancing cardiac perfusion by optimizing blood and oxygen delivery to the heart.
Major players in the Global Valsartan market are Jubilant Pharma, Sun Pharmaceutical, Teva, Mylan, Alembic Pharmaceuticals, Lupin, Novartis, Aurobindo Pharma, Macleods Pharmaceuticals, HETERO, Torrent Pharmaceuticals, Huaren Pharmaceutical, LG Life Sciences, Amneal Pharmaceuticals, Zhejiang Huahai Pharmaceutical, Square Pharmaceuticals, Unichem Laboratories, and Others.
Years considered for this report:
Historical Period: 2015- 2022
Base Year: 2023
Estimated Year: 2024
Forecast Period: 2025-2034
This report will be delivered on an online digital platform with one-year subscription and quarterly update.
Objective of the Study:
• To assess the demand-supply scenario of Valsartan which covers production, demand and supply of Valsartan market in the globe.
• To analyse and forecast the market size of Valsartan
• To classify and forecast Global Valsartan market based on end-use and regional distribution.
• To examine competitive developments such as expansions, mergers & acquisitions, etc., of Valsartan market in the globe.
To extract data for Global Valsartan market, primary research surveys were conducted with Valsartan manufacturers, suppliers, distributors, wholesalers and traders. While interviewing, the respondents were also inquired about their competitors. Through this technique, ChemAnalyst was able to include manufacturers that could not be identified due to the limitations of secondary research. Moreover, ChemAnalyst analyzed various segments and projected a positive outlook for Global Valsartan market over the coming years.
ChemAnalyst calculated Valsartan demand across the globe by analyzing the volume of Valsartan consumed by the End-Use Applications and the forecast is calculated based on the growth rate of end-use industries. ChemAnalyst sourced these values from industry experts and company representatives and externally validated them by analyzing the historical sales data of respective manufacturers to determine the overall market size. Various secondary sources such as company websites, association reports, annual reports, etc., were also studied by ChemAnalyst.
Key Target Audience:
• Valsartan manufacturers and other stakeholders
• Organizations, forums and alliances related to Valsartan distribution
• Government bodies such as regulating authorities and policy makers
• Market research organizations and consulting companies
The study is useful in providing answers to several critical questions that are important for industry stakeholders such as Valsartan manufacturers, customers and policy makers. The study would also help them to target the growing segments over the coming years, thereby aiding the stakeholders in taking investment decisions and facilitating their expansion.
Report Scope:
In this report, Global Valsartan market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Attribute
Details
Market size Volume in 2023
46 thousand tonnes
Market size Volume in 2034
75 thousand tonnes
Growth Rate
CAGR of 4.65% from 2024 to 2034
Base year
2023
Estimated year
2024
Historical Data
2015 – 2022
Forecast period
2025 – 2034
Quantitative units
Demand in thousand tonnes and CAGR from 2024 to 2034
Report coverage
Industry Market Size, Capacity by Company, Capacity by Location, Operating Efficiency, Production by Company, Demand by Type, Demand by End-Use Application, Demand by Region, 9. Demand by Distribution Channel, Demand-Supply Gap, Company Share, Manufacturing Process.
Segments covered
By End-Use Application: (Hypertension, Heart Failure, Heart Attack, and Others)
By Sales Channel: (Direct Sale and Indirect Sale)
Regional scope
North America, Europe, Asia Pacific, Middle East and Africa, and South America.
With the given market data, ChemAnalyst offers customizations according to a company’s specific needs.
In case you do not find what, you are looking for, please get in touch with our custom research team at sales@chemanalyst.com
Market Data & Insights
Table of Content
1. Industry Market Size
It is an essential metric for market analysis, as it provides insights into the overall size and growth potential of Valsartan market in terms of value and volume.
2. Capacity By Company
On our online platform, you can stay up to date with essential manufacturers and their current and future operation capacity on a practically real-time basis for Valsartan.
3. Capacity By Location
To better understand the regional supply of Valsartan by analyzing its manufacturers' location-based capacity.
4. Plant Operating Efficiency
To determine what percentage manufacturers are operating their plants or how much capacity is being currently used.
5. Production By Company
Study the historical annual production of Valsartan by the leading players and forecast how it will grow in the coming years.
6. Demand by Type
Learn about the various types of Valsartan - 40 mg Tablets, 80 mg Tablets, 160 mg Tablets, and 320 mg Tablets, and their demands. It will allow you to choose which type to concentrate on when designing your strategy.
7. Demand by End-Use Applications
Discover which end-user application (Hypertension, Heart Failure, Heart Attack, and Others) are creating a market and the forecast for the growth of the Valsartan market.
8. Demand by Region
Analyzing the change in demand of Valsartan in different regions, i.e., North America, Europe, Asia Pacific, Middle East and Africa, and South America, that can direct you in mapping the regional demand.
9. Demand by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
Multiple channels are used to sell Valsartan. Our Distribution Channel will help in analyzing whether Hospital Pharmacy, Retail Pharmacy, or Online Pharmacy make up most of the industry's sales.
10. Demand-Supply Gap
Determine the supply-demand gap to gain information about the trade surplus or deficiency of Valsartan.
11. Company Share
Figure out what proportion of the market share of Valsartan is currently held by leading players across the globe.
12. Manufacturing Process
Discover insights into the intricate manufacturing process of Valsartan.
I am satisfied with overall performance of ChemAnalyst. Weekly updates before the final report were especially helpful and reassuring. Additional requests on the interim and/or final reports were handled in a swift and professional manner
Mr.Shin Dosho
Member - Board of Directors
Osaka Gas Co. Ltd
Disruption Tracker
Disruption Tracker reflect the major shutdown on monthly basis which will help you in
tracking the inventory management and smooth functioning of business. Unforeseen shutdowns and disruptions
resulting in a loss of production capacity to impact the bottom line. The capacity tracker provides industries
with a global view of production and consumption capacity loss that reflects the corresponding conversion factors.
It also highlights the immediate impact on supply due to planned and unplanned outages as well as upcoming start-up
of new capacities. Additionally, it emphasizes how each shutdown—whether due to a maintenance turnaround or a case
of force majeure, affects the plant's operating rate for the given duration. Disruption tracker gives a clear insight
into the worldwide outages affecting the commodity of interest. With every shutdown, it also reflects the impact on
supply of the product in the market at a Global level.
What was the net market size of Valsartan in terms of volume in 2023?
Ans:
The global market size of Valsartan has reached approximately 46 thousand tonnes in 2023.
Q2.
Which region is a prominent consumer of Valsartan?
Ans:
North America is a prominent consumer of Valsartan globally.
Q3.
Do you offer single or multiuser license?
Ans:
Online Access 12 Months – Single User License (Up to 3 users can access the database) Online Access 12 Months – Enterprise License (Up to 10 Users can access the database)
Q4.
Will I get access to the analyst who authored this report?
Ans:
You will have 24/7 access to the analyst during the subscription period.
Our Solutions
Custom Research
We at ChemAnalyst provide tailor-made solutions to our clients based on their requirements which help them in building and expanding their business by developing customized strategy such as sales strategy, GTM Strategy, product portfolio and new product development. Our dedicated team helps clients in getting the best solution for their requirements. We at ChemAnalyst look forward to serving our clients for long term association.
Techno Economic Feasibility Report (TEFR)
ChemAnalyst provide TEFR reports which include market sizing, plant cost (ISBL and OSBL units), financial modelling, covering all the major financial calculations and ratios including production cost, IRR, major technology, licensing fee (if required), and others fixed and variable costs. TEFR reports will help the client to build greenfield project as well as brownfield expansion for a specific geography. Our Team of experts have delivered multiple TEFR reports which help clients in moving ahead of their business competition by grabbing the opportunity and expanding their business portfolio.
Price Benchmarking
Pricing benchmark report provides real-time data perpetuating current market scenarios, in a world that is changing at a rapid pace, having real-time prices is an imperative to make impactful insights and thereby informed decisions. The Price Benchmarking report provides pricing data for an individual market, or group of markets, which can be converted into localized insights and comparable listings. Benchmarking Reports help clients to make informed decisions by construing the data on several filters: region, country, category, grade and subsequently increasing their brand presence. Clients majorly require pricing benchmarks when they opt for a competitive pricing strategy.